Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glatiramer acetate (GA, Copolymer-1) an hypothetical treatment option for Rett syndrome.

Medical hypotheses - 1 Feb 2011

Ben-Zeev B, Aharoni R, Nissenkorn A, Arnon R

Abstract excerpt

Rett syndrome (RTT) is an X-linked dominant postnatal severe and disabling neurodevelopmental disorder which is the second most common cause for genetic mental retardation in girls and the first pervasive disorder with a known genetic basis. The syndrome is primarily caused by mutations in the Methyl CpG binding protein 2 (MECP2) gene on Xq28. Its protein product MeCP2 acts as a transcriptional repressor or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain-Derived Neurotrophic Factor
Share to Immunologic Factors
Share to Methyl-CpG-Binding Protein 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mice, Transgenic

Share to Models, Biological

Share to Peptides

Share to Rett Syndrome

Share to Transcription, Genetic

Source

Identifiers

PMID: 20951500
DOI: 10.1016/j.mehy.2010.09.015

Genes

BDNF
MECP2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glatiramer acetate (GA, Copolymer-1) an hypothetical treatment option for Rett syndrome.PMID 20951500Read ↗

Clinical-grade intranasal NGF fuels neurological and metabolic functions of Mecp2-deficient miceSemantic proximity Read ↗

Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome.Semantic proximity Read ↗

Circulating 4-F4t-Neuroprostane and 10-F4t-Neuroprostane Are Related to MECP2 Gene Mutation and Natural History in Rett Syndrome.Semantic proximity Read ↗

Environmental enrichment intervention for Rett syndrome: an individually randomised stepped wedge trial.Semantic proximity Read ↗

Modulation of RhoGTPases improves the behavioral phenotype and reverses astrocytic deficits in a mouse model of Rett syndrome.Semantic proximity Read ↗

GM1 Oligosaccharide Ameliorates Rett Syndrome Phenotypes In Vitro and In Vivo via Trk Receptor Activation.Semantic proximity Read ↗

Transcriptional Regulation of MECP2E1-E2 Isoforms and BDNF by Metformin and Simvastatin through Analyzing Nascent RNA Synthesis in a Human Brain Cell Line.Semantic proximity Read ↗

7,8-dihydroxyflavone exhibits therapeutic efficacy in a mouse model of Rett syndrome.Semantic proximity Read ↗

Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor.Semantic proximity Read ↗

[Nerve growth factors in future therapies. Protein mutation broadens the range of therapeutic possibilities].Semantic proximity Read ↗

Rett Syndrome: Treatment with IGF-1, Melatonin, Blackcurrant Extracts, and RehabilitationSemantic proximity Read ↗

Neuroactive Steroid Levels in a transgenic rat model of CMT1A Neuropathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.